VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $374,000 | -63.2% | 14,681 | -62.8% | 0.01% | -54.5% |
Q1 2022 | $1,015,000 | -58.4% | 39,458 | -32.2% | 0.01% | -52.2% |
Q4 2021 | $2,437,000 | -1.7% | 58,200 | +2.1% | 0.02% | -4.2% |
Q3 2021 | $2,480,000 | -13.3% | 56,991 | -5.8% | 0.02% | -7.7% |
Q2 2021 | $2,860,000 | -15.0% | 60,488 | -7.8% | 0.03% | -16.1% |
Q1 2021 | $3,363,000 | +51.1% | 65,586 | -21.1% | 0.03% | +47.6% |
Q4 2020 | $2,226,000 | -18.4% | 83,139 | +4.6% | 0.02% | -30.0% |
Q3 2020 | $2,729,000 | – | 79,505 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |